709-1099

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
709 (USA) · Dr. Novak
consented 2013-10-25

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ACROCHORDON EXCISION — outcome: RECOVERED/RESOLVED; onset 2014-03-23 (study day 150.0); relationship: NONE

mild assessed

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-12 (study day 19.0); relationship: PROBABLE

mild assessed

Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-06 (study day 13.0); relationship: NONE

mild assessed

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-11-06 (study day 13.0); relationship: NONE

Data queries

No data queries.